BRIEF published on 04/20/2026 at 11:18, 3 days 15 hours ago BNP Paribas Développement crosses a threshold at MEDICELL Euronext Paris Voting Rights BNP Paribas Threshold Crossing MEDICELL
BRIEF published on 04/02/2026 at 19:05, 21 days 7 hours ago Medincell: Update on capital and voting rights Share Capital Voting Rights Shares Euronext AMF
BRIEF published on 02/20/2026 at 21:42, 2 months 3 days ago Teva's Olanzapine Injectable Suspension Gains FDA Nod Schizophrenia Olanzapine Teva Pharmaceuticals FDA Acceptance Long-acting Injectable
PRESS RELEASE published on 02/20/2026 at 21:37, 2 months 3 days ago Inside Information / Other news releases FDA accepts Teva's NDA for once-monthly olanzapine for schizophrenia treatment, addressing treatment gap. Teva and Medincell collaborate for innovative solution FDA Schizophrenia Medincell Olanzapine Teva
BRIEF published on 02/19/2026 at 10:33, 2 months 4 days ago Mirova crosses a threshold at MEDINCELL Euronext Paris Voting Rights Transfer Of Shares Mirova MEDICELL
BRIEF published on 12/09/2025 at 14:55, 4 months 14 days ago Teva Pharmaceuticals submits an application for authorization for Olanzapine LAI FDA Schizophrenia Medincell Teva Pharmaceuticals Olanzapine LAI
BRIEF published on 12/09/2025 at 14:55, 4 months 14 days ago Medincell and Teva Submit FDA Application for New Injectable Treatment Schizophrenia Treatment Medincell FDA Submission Teva Pharmaceuticals Olanzapine LAI
PRESS RELEASE published on 12/09/2025 at 14:50, 4 months 14 days ago Inside Information / Other news releases Teva Pharmaceuticals submits NDA to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749 / mdc-TJK) for Once-Monthly Schizophrenia Treatment. Medincell focuses on long-acting injectable treatments across therapeutic areas Schizophrenia Medincell Olanzapine NDA Teva Pharmaceuticals
BRIEF published on 11/11/2025 at 08:05, 5 months 12 days ago Medincell Expands Dr Grace Kim's Role to Boost US Capital Growth Biotechnology Medincell Pharmaceutical Strategy Dr Grace Kim US Capital Growth
PRESS RELEASE published on 11/11/2025 at 08:00, 5 months 12 days ago Inside Information / Other news releases Medincell appoints Dr. Grace Kim as Chief Strategy Officer, U.S. Finance to lead U.S. capital growth strategy. Medincell pioneers long-acting injectable therapies Medincell Dr. Grace Kim Long-acting Injectable Therapies U.S. Capital Growth Clinical-stage Pharmaceutical Company
Published on 04/24/2026 at 00:25, 2 hours 1 minute ago Golden Lake Announces Closing Date of April 30, 2026 for Arrangement with McEwen Inc.
Published on 04/24/2026 at 00:15, 2 hours 11 minutes ago Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference Call
Published on 04/24/2026 at 00:00, 2 hours 26 minutes ago Onco-Innovations Advances Polymer Testing as It Moves Its PNKP Inhibitor Technology Toward IND-Enabling Studies
Published on 04/24/2026 at 00:00, 2 hours 26 minutes ago Redwood AI Announces Chemical Pricing and Availability System Update to Its AI-Powered Platform, Supported by Government of Canada Innovation Funding
Published on 04/23/2026 at 23:10, 3 hours 16 minutes ago AS Unternehmensgruppe – AS Invest Capital Ltd. Plans IPO for Early 2027 and Advances Next Phase of Growth
Published on 04/23/2026 at 21:40, 4 hours 46 minutes ago MaitriBodh Parivaar: Maitreya Dadashreeji's "Gross Peace Index" Proposal Gains Attention at Commonwealth Summit 2026
Published on 04/23/2026 at 18:30, 7 hours 56 minutes ago The Annual General Meeting approves all proposals
Published on 04/23/2026 at 18:30, 7 hours 56 minutes ago Readcrest Capital postpones the publication of its audited consolidated financial statements until mid-May 2026 – Sale of the UK nursing home business requires an adjusted presentation
Published on 04/23/2026 at 18:00, 8 hours 26 minutes ago Oxford Royale Academy Partners with MIT to Bring AI Education to Summer School Students
Published on 04/23/2026 at 19:27, 6 hours 59 minutes ago Annual Shareholders' Meeting 2026 - Conditions of availability of the preparatory documents
Published on 04/23/2026 at 18:18, 8 hours 7 minutes ago Aéroports de Paris SA - Sale by Groupe ADP of securities representing 3.4% with option to sell an additional 3.9% of GAL's equity share capital to GMR Group
Published on 04/23/2026 at 18:00, 8 hours 26 minutes ago 2025 Full-Year Results: Strong Top-Line Rebound (+26%)
Published on 04/23/2026 at 17:50, 8 hours 36 minutes ago Cegedim: Like-for-like revenues fell 0.8% in the first quarter of 2026
